| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery, Friedrich Alexander University of Erlangen (M.G.J., D.K.), Erlangen, Germany; Department of Surgery, University of Regensburg (U.B.), Regensburg, Germany; and Institute of Veterinary Biochemistry, Free University Berlin (R.E.), Berlin, Germany
Address all correspondence and requests for reprints to: Dr. Marc G. Jeschke, Shriners Hospital for Children, Galveston Burns Unit, 815 Market Street, Galveston, Texas 77550. E-mail: mcjeschke{at}hotmail.com.
Insulin decreases the mortality and prevents the incidence of infection and sepsis in critically ill patients. The molecular and cellular mechanisms by which insulin improves survival have not been defined. The purpose of the present study was to determine the effect of insulin on the inflammatory reaction during endotoxemia. Endotoxemic rats were randomly divided into two groups to receive either saline or insulin. The effects of insulin on hepatic signal transcription factor mRNA expression, proinflammatory and antiinflammatory cytokine mRNA and protein concentration were determined. Insulin administration did not change glucose or electrolyte levels, but significantly decreased proinflammatory signal transcription factors [CCAAT/enhancer-binding protein-ß, signal transducer and activator of transcription-3 and-5, RANTES (regulated on activation, normal T cell expressed and secreted)] and cytokine expression in the liver and serum levels of IL-1ß, IL-6, macrophage inflammatory factor, and TNF
. Insulin administration further decreased high mobility group 1 protein in the serum compared with controls. In addition, insulin increased antiinflammatory cytokine expression in the liver; serum levels of IL-2, IL-4, and IL-10; and hepatic suppressor of cytokine signaling-3 mRNA expression. Insulin modulates the inflammatory response by decreasing the proinflammatory and increasing the antiinflammatory cascade. Because glucose and electrolyte levels did not differ between insulin-treated patients and controls, we hypothesize that the effects are direct antiinflammatory mechanisms of insulin, rather than indirect, through modulation of glucose or electrolyte metabolism.
This article has been cited by other articles:
 |
|
 |
|
  P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty Insulin as an anti-inflammatory and antiatherogenic modulator. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chao and J. H. Page Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis Am. J. Epidemiol., September 1, 2008; 168(5): 471 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting Patients Ann. Thorac. Surg., July 1, 2008; 86(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Kidd, G. A. Schabbauer, J. P. Luyendyk, T. D. Holscher, R. E. Tilley, M. Tencati, and N. Mackma Insulin Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B (Akt) Pathway Reduces Lipopolysaccharide-Induced Inflammation in Mice J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. N. Das Glucose, insulin, and coronary heart disease Eur. Heart J., April 2, 2008; 29(8): 1075 - 1076. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population: The Bruneck Study Diabetes Care, February 1, 2007; 30(2): 318 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Viardot, S. T. Grey, F. Mackay, and D. Chisholm Potential Antiinflammatory Role of Insulin via the Preferential Polarization of Effector T Cells toward a T Helper 2 Phenotype Endocrinology, January 1, 2007; 148(1): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Van Wezel Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 224 - 227. [Abstract] [PDF]
|
|
|
|
|
|
U. N. Das Glucose, insulin, and acute myocardial infarction Eur. Heart J., September 1, 2006; 27(17): 2141 - 2142. [Full Text] [PDF]
|
|
|
|
|
|
I. Bergheim, J. P. Luyendyk, C. Steele, G. K. Russell, L. Guo, R. A. Roth, and G. E. Arteel Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Langouche, I. Vanhorebeek, and G. Van den Berghe Glycaemic control in trauma patients, is there a role? Trauma, January 1, 2006; 8(1): 13 - 19. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Visser, C. J. Zuurbier, F. J. Hoek, B. C. Opmeer, E. de Jonge, B. A. J. M. de Mol, and H. B. van Wezel Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery Br. J. Anaesth., October 1, 2005; 95(4): 448 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation Circulation, March 22, 2005; 111(11): 1448 - 1454. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dandona, A. Chaudhuri, and A. Aljada The Relationship of Fasting Serum Radioimmune Insulin Levels to Incident Coronary Heart Disease in an Insulin-Treated Diabetic Cohort J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5868 - 5869. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
